Otitis Media With Effusion and Type 2 Inflammation Diseases

Otitis Media With Effusion Among Patients With Type 2 Inflammation Diseases

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT06403319

Enrollment

100622

Registered

2024-05-07

Start date

2009-01-01

Completion date

2020-12-31

Last updated

2024-05-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Otitis Media With Effusion

Brief summary

Otitis media with effusion (OME) is thought to be associated with comorbidities such as allergic rhinitis, gastroesophageal reflux disease, asthma, and more. Many of these comorbidities can be caused by type 2 inflammation (T2I). This study aims to characterize the risk of undergoing OME surgery. This retrospective, matched-cohort study involved the retrospective recruitment of patients from 2009 to 2020, using the Taiwan National Health Insurance Research Database (NHIRD)

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Healthy volunteers

Yes

Inclusion criteria

* Diagnosis of OME * At least two outpatient visits or one hospitalization record * Medical records within the database

Exclusion criteria

* Participants younger than 4 years old * Participants with unclear demographic information * Participants with a history of ear surgery or congenital ear anomalies * Participants who had undergone OME surgery before the index date

Design outcomes

Primary

Measure	Time frame	Description
The number of participants with OME who requiring surgical intervention	10 years	surgical intervention including procedures such as myringotomy and adenoidectomy

Outcome results